Most biosimilars are mainly available to patients as provider-administered infusions in institutional settings such as hospitals and doctors’ offices and these financial transactions generally happen outside of the PBM-retail pharmacy payment chain.
(Washington, D.C.) — FMI – The Food Industry Association, the National Association of Chain Drug Stores (NACDS), National Community Pharmacists Association (NCPA), National Grocers Association (NGA), and the Pharmaceutical Care Management Association (PCMA) today issued the following joint statement outlining
President, CarelonRx As president of CarelonRx, Paul Marchetti is responsible for advancing the company’s integrated, whole-person approach to care delivery and for driving programs and strategies that lead to improved affordability and outcomes. Paul has more than 25 years of
PBMs are committed to helping the patients we serve stay at home safely with reliable, convenient access to their needed prescription drugs. PBMs recognize that home delivery can provide an alternative way of safely accessing needed maintenance medications and
COVID-19: Frequently Asked Questions PBMs have substantial experience helping patients get the drugs and vaccines they need, including in times of crisis. PBMs are taking action to help educate the patients we serve about the safety and efficacy of authorized
A recent white paper (“The Association Between Drug Rebates and List Prices”) narrowly suggests an association between list prices for brand drugs and the rebate practices of pharmacy benefit managers (PBMs) and insurers, despite an underlying methodology that is notably broader
©2024 PCMA. All Rights Reserved.
